Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives $31.86 Average Price Target from Analysts
Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) have been given a consensus rating of “Buy” by the nine analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on […]
Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) have been given a consensus rating of “Buy” by the nine analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on […]
